A tissue-bioengineering strategy for modeling rare human kidney diseases in vivo
The lack of animal models for some human diseases precludes our understanding of disease mechanisms and our ability to test new therapies in vivo. Here the authors present a tissue bioengineering strategy for the study of a rare kidney tumor called angiomyolipoma, in vitro and in vivo, using patient...
Guardado en:
Autores principales: | J. O. R. Hernandez, X. Wang, M. Vazquez-Segoviano, M. Lopez-Marfil, M. F. Sobral-Reyes, A. Moran-Horowich, M. Sundberg, D. O. Lopez-Cantu, C. K. Probst, G. U. Ruiz-Esparza, K. Giannikou, R. Abdi, E. P. Henske, D. J. Kwiatkowski, M. Sahin, D. R. Lemos |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/928c67a16e704b9e921c20f97413c1e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioengineering
Publicado: (2014) -
Corneal reconstruction by stem cells and bioengineering
por: Arjamaa O
Publicado: (2012) -
Recent Advances in Kidney Bioengineering
por: Nina Cintron Pregosin, et al.
Publicado: (2021) -
Bioengineering the spider silk sequence to modify its affinity for drugs
por: Kucharczyk K, et al.
Publicado: (2018) - AIMS bioengineering